Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.25M Sell
6,403
-328
-5% -$117K 0.16% 80
2025
Q4
$2.2M Buy
6,731
+86
+1% +$27.3K 0.16% 83
2025
Q3
$1.88M Sell
6,645
-72
-1% -$20.9K 0.16% 74
2025
Q2
$1.88M Sell
6,717
-78
-1% -$22.1K 0.18% 72
2025
Q1
$2.12M Sell
6,795
-229
-3% -$67.6K 0.22% 65
2024
Q4
$1.83M Sell
7,024
-92
-1% -$27.3K 0.19% 68
2024
Q3
$2.29M Buy
7,116
+1,053
+17% +$344K 0.23% 62
2024
Q2
$1.89M Sell
6,063
-9
-0.1% -$2.64K 0.21% 65
2024
Q1
$1.73M Buy
6,072
+92
+2% +$26.9K 0.2% 66
2023
Q4
$1.72M Buy
5,980
+89
+2% +$24.3K 0.23% 63
2023
Q3
$1.58M Buy
5,891
+190
+3% +$47.4K 0.25% 60
2023
Q2
$1.27M Sell
5,701
-44
-0.8% -$10.2K 0.2% 66
2023
Q1
$1.39M Buy
5,745
+1,076
+23% +$264K 0.24% 59
2022
Q4
$1.23M Buy
4,669
+2,079
+80% +$557K 0.22% 63
2022
Q3
$584K Buy
2,590
+342
+15% +$82.9K 0.12% 106
2022
Q2
$547K Buy
2,248
+191
+9% +$46.8K 0.12% 111
2022
Q1
$497K Buy
2,057
+602
+41% +$138K 0.09% 146
2021
Q4
$328K Buy
+1,455
New +$307K 0.07% 205

Other funds holding AMGN

Quent Capital's AMGN Position: Q1 2026 in Review

Quent Capital reduced its Amgen (AMGN) stake by 4.9% in Q1 2026, selling an estimated $117K and leaving 6,403 shares worth $2.25M. The position accounts for 0.16% of the portfolio, ranked #80.

Quent Capital first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.29M in Q3 2024. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Quent Capital held 6,403 shares of Amgen worth $2.25M as of Q1 2026.
  • Quent Capital sold 328 Amgen shares in Q1 2026, an estimated $117K.
  • Amgen made up 0.16% of Quent Capital's portfolio in Q1 2026, its #80 holding.
  • Quent Capital first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
  • Quent Capital's Amgen position peaked at $2.29M in Q3 2024.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.